One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery.

[1]  W. S. Hummers,et al.  Preparation of Graphitic Oxide , 1958 .

[2]  P. Capdevielle,et al.  Mechanism of primary aliphatic amines oxidation to nitriles by the cuprous chloride - dioxygen - pyridine system , 1990 .

[3]  L. Frémont Biological effects of resveratrol. , 2000, Life sciences.

[4]  Ralph Weissleder,et al.  Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.

[5]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[6]  J. Fréchet,et al.  pH-Responsive copolymer assemblies for controlled release of doxorubicin. , 2005, Bioconjugate chemistry.

[7]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[8]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. , 2006, Biomaterials.

[9]  Andre K. Geim,et al.  Raman spectrum of graphene and graphene layers. , 2006, Physical review letters.

[10]  S. Stankovich,et al.  Preparation and characterization of graphene oxide paper , 2007, Nature.

[11]  Zhuang Liu,et al.  PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.

[12]  Zhuang Liu,et al.  Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.

[13]  Younan Xia,et al.  Gold nanocages covered by smart polymers for controlled release with near-infrared light , 2009, Nature materials.

[14]  Kian Ping Loh,et al.  Hydrothermal Dehydration for the “Green” Reduction of Exfoliated Graphene Oxide to Graphene and Demonstration of Tunable Optical Limiting Properties , 2009 .

[15]  Rodolfo Cruz-Silva,et al.  Flash reduction and patterning of graphite oxide and its polymer composite. , 2009, Journal of the American Chemical Society.

[16]  Michael J Sailor,et al.  Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery , 2009, Advanced materials.

[17]  Kai Yang,et al.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. , 2010, Nano letters.

[18]  Xingfa Gao,et al.  Hydrazine and Thermal Reduction of Graphene Oxide: Reaction Mechanisms, Product Structures, and Reaction Design , 2010 .

[19]  G. Eda,et al.  Graphene oxide as a chemically tunable platform for optical applications. , 2010, Nature chemistry.

[20]  Tingting Zheng,et al.  Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery , 2011 .

[21]  H. Dai,et al.  Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. , 2011, Journal of the American Chemical Society.

[22]  Xin Cai,et al.  A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. , 2011, Journal of the American Chemical Society.

[23]  Liangzhu Feng,et al.  Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. , 2011, ACS nano.

[24]  Luwei Chen,et al.  One-step synthesis of NH2-graphene from in situ graphene-oxide reduction and its improved electrochemical properties , 2011 .

[25]  Mark C Hersam,et al.  Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. , 2011, Nano letters.

[26]  Jing Wang,et al.  Mesoporous Silica‐Coated Gold Nanorods as a Light‐Mediated Multifunctional Theranostic Platform for Cancer Treatment , 2012, Advanced materials.

[27]  X. Zheng,et al.  Restoring basal planes of graphene oxides for highly efficient loading and delivery of β-lapachone. , 2012, Molecular pharmaceutics.

[28]  Jianping Gao,et al.  One pot preparation of reduced graphene oxide (RGO) or Au (Ag) nanoparticle-RGO hybrids using chitosan as a reducing and stabilizing agent and their use in methanol electrooxidation , 2012 .

[29]  Hui‐Ming Cheng,et al.  The reduction of graphene oxide , 2012 .

[30]  Kai Yang,et al.  The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. , 2012, Biomaterials.

[31]  R. Xiang,et al.  The preparation of functionalized graphene oxide for targeted intracellular delivery of siRNA , 2012 .

[32]  S. Bose,et al.  Chemical functionalization of graphene and its applications , 2012 .

[33]  Fong-Yu Cheng,et al.  Near‐Infrared Light‐Responsive Intracellular Drug and siRNA Release Using Au Nanoensembles with Oligonucleotide‐Capped Silica Shell , 2012, Advanced materials.

[34]  Tongsheng Chen,et al.  Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. , 2012, Cellular signalling.

[35]  Kai Yang,et al.  Behavior and toxicity of graphene and its functionalized derivatives in biological systems. , 2013, Small.

[36]  Won Jong Kim,et al.  Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. , 2013, ACS nano.

[37]  Gil Gonçalves,et al.  Nano‐Graphene Oxide: A Potential Multifunctional Platform for Cancer Therapy , 2013, Advanced healthcare materials.

[38]  S. Mohapatra,et al.  A chitosan-modified graphene nanogel for noninvasive controlled drug release. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[39]  Tongsheng Chen,et al.  Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine , 2013, Apoptosis.

[40]  Kai Yang,et al.  Nano-Graphene in Biomedicine: Theranostic Applications , 2013 .

[41]  A. Bianco,et al.  Graphene-based nanomaterials for nanobiotechnology and biomedical applications. , 2013, Nanomedicine.